SAB inhibits the growth of TGF-β1-induced A549 human non-small cell lung cancer (NSCLC) cells by inactivating mitogen-activated protein kinase (MAPK) and phosphorylating Smad2/3 [50]. Here, SMAD2 is linked to non-small cell lung carcinoma.